baber/WOPTO huggingface dataset:
Patent JP-2023542427-A (JP)
Title: 低コスト高性能ｑ５００橋梁用鋼および生産方法
IPC: C22C38/00
Filed: 2020-11-04
Abstract: 本発明は、低コスト高性能Ｑ５００橋梁用鋼を開示し、鉄鋼生産の技術分野に関し、その化学成分および質量％は以下のとおりであり：Ｃ≦０．０３５％、Ｓｉ：０．３１％～０．４０％、Ｍｎ：１．７１％～１．８０％、Ｐ≦０．０１５％、Ｓ≦０．００３０％、Ｎｂ：０．０３０％～０．０５０％、Ｖ：０．０２０％～０．０５０％、Ｔｉ：０．０１０％～０．０１８％、Ｃｒ：０．７０％～０．８０％、Ｎｉ：０．１０％～０．２０％、残留Ｍｏ≦０．０５％、Ｃｕ：０．１０％～０．２０％、Ｂ≦０．０００５％、Ｎ≦０．０００５％、Ａｌ：０．０２０％～０．０５０％。降伏強度を下げる同時に製品の引張強度を高め、製品の降伏比を効果的に低下させる。 
【選択図】図１
Patent JP-2023550812-A (JP)
Title: グラフェン加工技術
IPC: C01B32/194
Filed: 2021-11-25
Abstract: 本発明は、数層グラフェンをポリ(アルキレンオキシド)と組み合わせる工程、乾燥させてグラフェン/ポリ(アルキレンオキシド)複合体を形成する工程、およびこのようにして形成されたグラフェン/ポリ(アルキレンオキシド)複合体を不活性雰囲気中で焼成する工程を含む、グラフェンを加工する方法に関する。本発明は、数層という特徴を含む加工グラフェンであって、約1.5nm～約3.5nmの寸法を有する面内ナノ細孔、50％超の拡大した層間格子、3.40Å超の拡大層間距離、および4％未満の原子O/C含有率より選択される1つまたは複数の特徴をさらに含む、加工グラフェンにも関する。本発明は加工グラフェンを含むカソードおよび電池、ならびに容量性脱イオンまたは再充電可能な電池用途における加工グラフェンの使用にさらに関する。
Patent JP-2024501089-A (JP)
Title: ブタ赤痢に対する免疫原性及びワクチン組成物
IPC: A61K39/02
Filed: 2021-12-28
Abstract: 本発明は、Ｂｒａｃｈｙｓｐｉｒａ ｈｙｏｄｙｓｅｎｔｅｒｉａｅ種由来の不活性化細菌を含む免疫原性またはワクチン組成物、当該組成物を生産する方法、及びＢｒａｃｈｙｓｐｉｒａ ｈｙｏｄｙｓｅｎｔｅｒｉａｅ種由来の細菌に対する免疫応答を誘導するための、またはＢｒａｃｈｙｓｐｉｒａ ｈｙｏｄｙｓｅｎｔｅｒｉａｅ種由来の細菌に起因する感染症から防御するための、この組成物の医療的使用に関する。さらに、本発明は、ブタ赤痢に対するワクチンの製造に有用なＢｒａｃｈｙｓｐｉｒａ ｈｙｏｄｙｓｅｎｔｅｒｉａｅ種由来の細菌を選択する方法にも関する。【選択図】なし
Patent MX-2007002549-A (MX)
Title: Medical effector system.
Inventor: MARTIN JAMES F
IPC: G16H10/60
Filed: 2005-08-24
Abstract: A medical effector system comprised of a bedside unit and a procedure unit. Thebedside unit contains connection points for an oral nasal cannula and for receivinginputs from a series of patient monitors. The procedure unit contains a patientmonitoring and a medical effector program, and a drug delivery pump and drug cassetteor a magnetic flux generator capable of delivering therapeutic energy to a patient.The medical effector program operates the pump or magnetic flux generator basedupon at least some of the patient outputs and program inputs. A removable umbilicalcable connects the two units and allows gases, the patient monitors as well asother information to travel between the two units.
Patent MX-2007003021-A (MX)
Title: Composition useful for providing nox removing coating on material surface.
Inventor: STRATTON JOHN
IPC: C09D7/61
Filed: 2004-09-14
Abstract: The present invention relates to a composition having photocatalytic self icleaning properties for use as a NO, removing coating on material ;surface, comprising at least: a) photocatalytic titanium dioxide particles having at least a de-NOX activity, b) particles having a de-HNO3 activity, c) an opacifying agent, and d) a silicon based-material in which said particles are dispersed, wherein said photocatalytic particles have a crystalline size ranging from 1 to 50 nm.
Patent MX-2007003241-A (MX)
Title: Surgical system having a non-invasive flow sensor.
Inventor: WILLIAMS DAVID L
IPC: G01F1/00
Filed: 2007-03-20
Abstract: A surgical system having a console that receives a cassette with a rigid fluid channel formed into a rigid plastic component or housing. The housing serves as a substrate for an elastomeric acoustic coupling that can be formed on the housing outside of the fluid channel. The acoustic transducer is elastically mounted within the console, such as on a spring, so as to provide a relatively constant force between the transducer and the acoustic coupling when the cassette is installed in the console.
Patent MX-2007007590-A (MX)
Title: Compositions containing, methods involving, and uses of non-natural amino acids and polypeptides.
Inventor: MIAO ZHENWEI
IPC: C07K1/02
Filed: 2005-12-21
Abstract: Disclosed herein are non-natural amino acids and polypeptides that include at least one non-natural amino acid, and methods for making such non-natural amino acids and polypeptides. The non-natural amino acids, by themselves or as a part of a polypeptide, can include a wide range of possible functionalities, but typical have at least one oxime, carbonyl, dicarbonyl, and/or hydroxylamine group. Also disclosed herein are non-natural amino acid polypeptides that are further modified post-translationally, methods for effecting such modifications, and methods for purifying such polypeptides. Typically, the modified non-natural amino acid polypeptides include at least one oxime, carbonyl, dicarbonyl, and/or hydroxylamine group. Further disclosed are methods for using such non-natural amino acid polypeptides and modified non-natural amino acid polypeptides, including therapeutic, diagnostic, and other biotechnology uses.
Patent MX-2007009261-A (MX)
Title: Children's ride-on vehicle charging assemblies with back feed protection.
Inventor: DROSENDAHL STEVEN ROBERT
IPC: B62K1/00
Filed: 2006-02-01
Abstract: Battery charging assemblies for children's ride-on vehicles, and children's ride-on vehicles that include the same. The charging assemblies may include a power adapter that is adapted to be electrically connected to a power source, a charger cord, and a charging connector that is adapted to electrically interconnect with the rechargeable battery of the ride-on vehicle. The battery charging assemblies further include at least one protective element to prevent or significantly reduce backflow current from the battery into the battery charging assembly. The protective element may be located in the charging probe or at any point along the charger cord of the battery charging assembly. The protective element may include any suitable current- limiting or current-interrupting device. Examples of such current limiting devices include, without limitation, a fuse, a circuit breaker, an anti-backflow diode, and a resettable fuse such as a positive temperature coefficient resistor (PTC resistor).
Patent MX-2007009335-A (MX)
Title: Local treatment of neurofibromas.
Inventor: CHEN RUIHONG
IPC: A61K31/196
Filed: 2006-02-02
Abstract: A method for treating a neurofibroma, e.g. dermal neurofibroma, a subdermal neurofibroma, or a superficial plexiform neurofibroma, in a subject in need of such treatment is disclosed. The method comprises locally applying a composition to a neurofibroma either topically or intralesionally. This method does not encompass systemic administration of the composition to the subject to have an effect on the neurofibromas. Compositions useful for such treatments and methods of preparing the compositions are disclosed.
Patent MX-2007009381-A (MX)
Title: Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same.
Inventor: UPASANI RAVINDRA B
IPC: C07D405/14
Filed: 2006-02-24
Abstract: Compounds are disclosed that have a formula represented by the following: The compounds may be prepared as pharmaceutical compositions, and may be used for the prevention and treatment of a variety of conditions in mammals including humans, including by way of non-limiting example, pain, inflammation, traumatic injury, and others.
Patent MX-2007010728-A (MX)
Title: Substituted oxa-diaza-spiro-[5.5]-undecanone derivatives and their use as neurokinin antagonists.
Inventor: COUPA SOPHIE
IPC: A61K31/537
Filed: 2006-03-03
Abstract: This invention concerns substituted oxa-diaza-spiro-[5.5]-undecanone derivatives having neurokinin antagonistic activity, in particular an NK<sub>1</sub> antagonistic activity, an NK<sub>3</sub> antagonistic activity, a combined NK<sub>1</sub>/NK<sub>2</sub> antagonistic activity and a combined NK<sub>1</sub>/NK<sub>2</sub>/NK<sub>3</sub> antagonistic activity, their preparation, compositions comprising them and their use as a medicine, in particular for the treatment and/or prophylaxis of schizophrenia, emesis, anxiety and depression, irritable bowel syndrome (IBS), circadian rhythm disturbances, pre-eclampsia, nociception, pain, in particular visceral and neuropathic pain, pancreatitis, neurogenic inflammation, asthma, chronic obstructive pulmonary disease (COPD) and micturition disorders such as urinary incont inence. The compounds according to the invention can be represented by general Formula (I) and comprises also the pharmaceutically acceptable acid or base addition salts thereof, the stereochemically isomeric forms thereof, the N-oxide form thereof and prodrugs thereof, wherein all substituents are defined as in Claim 1.
Patent MX-2007016527-A (MX)
Title: Breath actuated nasal drug delivery system.
Inventor: WILLIAMS ROBERT
IPC: A61M15/00
Filed: 2006-04-07
Abstract: A method of high-speed processing and monitoring of a product, such as a pharmaceutical powder or tablet, comprises: moving the product (C) past an inspection station; illuminating at least a portion of the product with light; spectrally filtering a first portion of light carrying invormation about the product, o.g., transmitted or reflected light, by passing said first portion through at least one multivariate optical element (148) and detecting said filtered light with a first detector (152),- detecting a deflected second portion of said light with a second detector (156); and determining at least one selected property of the product based on the detector outputs.
Patent MX-2008000342-A (MX)
Title: Fentanyl formulation containing an essential oil.
Inventor: ROSS CALVIN
IPC: A61K9/00
Filed: 2006-07-07
Abstract: Formulations of fentanyl, especially pump spray formulations suitable for sublingual delivery, contain a low amount of methanol.
Patent MX-2008007486-A (MX)
Title: Self-concentrating solar converter with multiple joints and variable interconnections between cells.
Inventor: HERNANDEZ JESUS GONZALEZ
IPC: H01L31/00
Filed: 2008-06-10
Abstract: The present invention describes a photovoltaic device with multiple joints for converting solar energy into electric energy. The device consists of three solar cells optically connected in series, which are made of semiconducting materials, where the forbidden energy bands are selected for achieving an optimum absorption of the solar radiation. One of the cells, the one with a higher energy band, is physically separated from the other two cells that form a double-joint tandem structure (p-i-n). The first cell is designed in such a manner that the solar radiation portion which photons have an energy lower than that of the forbidden power band is reflected. A cell arrangement of said type acts as a reflector and concentrator of the reflected radiation, which comes into contact with other arrangement of several solar cells in a tandem structure of 2 joints (p-i-n) located in the focal plane of the concentrator mirror. The cell 1 is connected in parallel to the tandem cell of two joints.
Patent MX-2008008328-A (MX)
Title: (indazol-5-yl)-pyrazines and (1,3-dihydro-indol-2-one)- pyrazines for treating rho kinase-mediated diseases and conditions.
Inventor: HELLBERG MARK R
IPC: A61K31/4965
Filed: 2006-12-19
Abstract: Methods for using (indazol-5-yl)-pyrazines and (1,3-dihydro-indol-2-one)-pyrazines are disclosed herein to treat rho kinase-mediated diseases or rho kinase-mediated conditions, including controlling intraocular pressure and treating glaucoma, are disclosed. Ophthalmic pharmaceutical compositions useful in the treatment of eye diseases such as glaucoma, and additionally useful for controlling intraocular pressure, the compositions comprising an effective amount of (indazol-5-yl)-pyrazines and (1,3-dihydro-indol-2-one)-pyrazines, are disclosed herein.
Patent MX-2008009984-A (MX)
Title: Film-forming material containing phosphorous and methods of producing coating compositions containing phosphorous.
Inventor: DECEMBER TIMOTHY S
IPC: C08J5/00
Filed: 2008-01-07
Abstract: Film-forming materials include resins having a covalently bonded phosphorous atom, the phosphorous atom having at least one covalently bonded oxygen atom. Film-forming resins containing phosphorous can include epoxy, acrylic, polyurethane, polycarbonate, polysiloxane, polyvinyl, polyether, aminoplast, and polyester resins. A process to produce a film-forming resin includes reacting various polymers to incorporate a pendent group comprising a covalently bonded phosphorous atom. Methods of making a coating composition including a film-forming material having a covalently bonded phosphorous atom, the phosphorous atom having at least one covalently bonded oxygen atom. Coating compositions can be used to coat a substrate, such as a metal substrate, by electrodeposition. Applied coatings containing the film-forming resins can be cured to form crosslinked films on substrates.
Patent MX-2008010884-A (MX)
Title: 4-phenyl-thiazole-5-carboxylic acids and 4-phenyl-thiazole-5-carb oxylic acid amides as plk1 inhibitors.
Inventor: FOTOUHI NADER
IPC: C07D417/04
Filed: 2007-02-19
Abstract: The invention is directed to compounds of formula (1) and pharmaceutically acceptable salts thereof, methods for the preparation thereof, and methods of use thereof.
Patent MX-2008013048-A (MX)
Title: Weighted determination in configuration management systems.
Inventor: RAMACHANDRAN PUTHUKODE
IPC: H04L12/24
Filed: 2007-03-28
Abstract: A system, method, and medium for providing configurable item configuration data by receiving a plurality of configuration data sets from a plurality of sources, all which pertain to the same configurable item (CI), then using weighting rules and preferences to assign weight values for each option, feature, and component in each report according to discrepancies and commonalities between the data sets, creating a new data set for the configurable item by selecting options, features, and components having the greatest weight values among all of the data sets, assigning confidence factors to each option, feature, and component by weight comparisons between the plurality of data sets; updating a configuration management database entry for the configurable item accordingly. The confidence factors are useful for inhibiting regulated processes, such as software release processes and change control processes, and for generating human-readable configuration reports indicating confidence levels of the reports and their contents.
Patent MX-2008013619-A (MX)
Title: Augmentation of titer for vaccination in animals.
Inventor: PUNTENNEY STEVEN BRUCE
IPC: A61K35/02
Filed: 2007-04-19
Abstract: The disclosure relates to a composition added to animal feed used in combination with a vaccine to enhance the effectiveness of the vaccine. Amongst other effects, the composition raises the titer of antibodies to the vaccine.
Patent MX-2009000216-A (MX)
Title: Low-profile cable.
Inventor: MARTIN RALPH SYKES
IPC: H01B11/04
Filed: 2009-01-07
Abstract: A low-profile cable is provided and includes a body having upper and lower portions that extend a length of the body and also having opposite sidewalls joining the upper and lower portions to one another. The cable also includes passages that are located between the sidewalls. The passages extend the length of the body and are configured to receive at least one twisted pair of conductors. Also, the cable includes a load-bearing structural section that spans between the upper and lower portions. The structural section includes opposing wall supports separated by a pocket channel therebetween. The structural section is configured to support the upper and lower portions and substantially resist deformation of the passages when external forces are induced onto at least one of the upper and lower portions.
Patent MX-2009000283-A (MX)
Title: Chemical compounds.
Inventor: BARRACLOUGH PAUL
IPC: A23L33/00
Filed: 2007-07-05
Abstract: Compounds of general formula (I) wherein: R<sub>1</sub> and R<sub>2</sub> are, independently of each other, selected from hydrogen, optionally substituted C<sub>1-10</sub>alkyl, optionally substituted -CO-(C<sub>1-10</sub>alkyl), optionally substituted C<sub>3-10</sub>cycloalkyl, optionally substituted -CO-(C<sub>3-10</sub>cycloalkyl), optionally substituted C<sub>2-10</sub>alkenyl, optionally substituted -CO-(C<sub>2-10</sub>alkenyl), optionally substituted aryl, and optionally substituted -CO-aryl, or R<sub>1</sub> and R<sub>2</sub> together represent an optionally substituted saturated or unsaturated C<sub>1-10</sub>alkylidene group, or an optionally substituted saturated or unsaturated C<sub>3-10</sub>cycloalkylidene group, or R<sub>1</sub> and R<sub>2</sub> together with the carbon atom to which they are attached represent an optionally substituted saturated or unsaturated organic ring containing 3, 4, 5, 6, 7 or 8 ring carbon atoms and optionally 1, 2 or 3 ring heteroatoms selected from O, N and S; R<sub>3</sub>, which may be the same as, or different from, either of R<sub>1</sub> and R<sub>2</sub>, is selected from optionally substituted C<sub>1-10</sub>alkyl, optionally substituted C<sub>3-10</sub>cycloalkyl, optionally substituted C<sub>2-10</sub>alkenyl, and optionally substituted aryl; R<sub>4</sub>, R<sub>5</sub> and R<sub>6</sub> are, independently of each other, selected from hydrogen, optionally substituted C<sub>1-10</sub>alkyl, OH, optionally substituted C<sub>1-10</sub>alkoxy, halo, optionally substituted aryloxy, optionally substituted (C<sub>1-10</sub>alkyl)-S(O)<sub>n</sub>- where n = 0, 1 or 2, optionally substituted aryl-S(O)<sub>n</sub>- where n = 0, 1 or 2, or R<sub>4</sub> is hydrogen and R<sub>5</sub> and R<sub>6</sub> together represent an optionally substituted saturated or unsaturated organic chain containing 1, 2, 3, 4, 5, 6 or 7 chain carbon atoms and optionally 1, 2 or 3 chain heteroatoms selected from O, N and S, provided that the chain is at least 3 atoms long; with the proviso that, when R<sub>1</sub> = R<sub>2</sub> = hydrogen, then any optionally substituted C<sub>1-10</sub>alkyl or optionally substituted C<sub>2-10</sub>alkenyl for R<sub>3</sub> must have a branch point at one or more of the alpha and beta positions counted from the carbonyl group (or tautomeric form thereof) to which R<sub>3</sub> is attached; or a physiologically acceptable salt, complex or prodrug thereof; are disclosed <i>per se</i> and for use in the treatment or prophylaxis of hypersensitivity, smooth muscle disorders, spasmodic conditions, allergic conditions, inflammatory conditions and/or pain.
Patent MX-2009000483-A (MX)
Title: Medication applicator device.
Inventor: LADD LORI A
IPC: A61M31/00
Filed: 2007-07-09
Abstract: A device for inserting medication into a cavity of a body comprising a syringe having a barrel member and a plunger, the plunger having an end for movable interaction with the barrel member, the end comprising a seat configured to allow seating of the medication therein.
Patent MX-2009000600-A (MX)
Title: Hose and tubing assemblies and mounting systems and methods.
Inventor: RAILSBACK LAYNE
IPC: F16L3/123
Filed: 2007-07-13
Abstract: A hose assembly (100) includes a length of hose (101) and a bracket (102). The bracket includes a rigid insert (103) and a resilient overmold (105) encapsulating at least a portion of the insert and mechanically bonding with at least a portion of an exterior of the hose. A method to produce this assembly may employ thermoplastic injection molding and include the steps of associating the rigid insert with the length of hose and overmolding the rigid insert and a section of the length of hose associated with the rigid insert with the resilient material, thereby encapsulating a portion of the insert and mechanically bonding the resilient material with the section of the length of the hose. A portion of the rigid insert may extend from the bracket and provide mounting holes and a bearing surface for mounting fasteners.
Patent MX-2009004704-A (MX)
Title: Electric plasma-mediated cutting and coagulation of tissue and surgical apparatus.
Inventor: PALANKER DANIEL V
IPC: A61B18/14
Filed: 2007-11-01
Abstract: Electrosurgery method and apparatus. In the method, tissue is cut or coagulated, with an electrically low conductive liquid providing cooling. In another method, skin is cut by electrosurgery in a dry field using a low duty cycle signal energizing the cutting electrode, minimizing tissue charring. A combination coagulation and cutting electrode performs both functions. The cutting is performed by a blade edge generating a local plasma adapted for cutting. Superimposed on the blade edge is an electrode of greater surface area electrically insulated from the cutting electrode, for coagulation. In another version, a single component cutting/coagulation blade (electrode) has a cutting and a flat partially insulated portion defining through holes in the insulation for coagulation. Also provided is an electrical circuit whereby each electrode is isolated by a filter from cross talk and feedback of the RF signal from the other electrode, minimizing arcing.
Patent MX-2009008607-A (MX)
Title: Method for producing methyl mercaptan from dialkyl sulfides and dialkyl polysulfides.
Inventor: HUTHMACHER KLAUS
IPC: C07C321/04
Filed: 2008-01-16
Abstract: The invention relates to a method for the continuous production of methyl mercaptan by reacting an educt mixture containing dialkyl sulfides and dialkyl polysulfides, with hydrogen sulfide in order to form methyl mercaptan.
Patent MX-2009011900-A (MX)
Title: Diabetic wound healing.
Inventor: BARBER JACK R
IPC: A61K31/4545
Filed: 2008-05-05
Abstract: The present invention provides methods of enhancing healing of wound associated with diabetes, comprising administering an effective amount of one or more of certain hydroxylamine derivatives to a subject in need thereof. The invention also provides pharmaceutical compositions comprising a certain hydroxylamine derivative or a pharmaceutically acceptable salt thereof, optionally in combination with one or more additional therapeutic agents. In certain compositions and methods, the additional therapeutic agent is a second hydroxylamine derivative or a pharmaceutically acceptable salt thereof.
Patent MX-2010000044-A (MX)
Title: Digital broadcasting system and method of processing data.
Inventor: CHOI IN HWAN
IPC: H04N19/89
Filed: 2008-07-04
Abstract: A digital receiving system, and a method of processing data are disclosed. The digital receiving system includes a receiving unit, a known sequence detector, and a channel equalizer. The receiving unit receives a broadcast signal including mobile service data and main service data. The known sequence detector detects known data linearly inserted in a data group. The channel equalizer performs channel-equalizing on the received mobile service data using the detected known data.
Patent MX-2010005300-A (MX)
Title: 4-pyrazolyl-n-arylpyrimidin-2-amines and 4-pyrazolyl-n-heteroaryl pyrimidin-2-amines as janus kinase inhibitors.
Inventor: RODGERS JAMES D
IPC: C07D498/10
Filed: 2008-11-13
Abstract: The present invention provides substituted bicyclic heteroaryl compounds, 5 including, for example, 4-pyrazoIyI-N-arylpyrirnidin-2-arnines and 4-pyrazolyl-N-heteroarylpyÏimidin-2-amines that modulate the activity of kinases and are useful in the treatment of diseases related to activity of kinases including, for example, immune-related diseases, skin disorders, myeloid proliferative disorders, cancer, and other diseases.formule :(1).
Patent MX-2010010331-A (MX)
Title: Molded thermoplastic articles.
Inventor: ZAWACKI JEFFREY RUSSELL
IPC: B29C45/00
Filed: 2009-03-26
Abstract: An injection molded foam article including a structure and a projection projecting from the structure. The thickness of the projection is greater than 25% to 40% of the thickness of the structure, depending on the material of the article, and the front surface of the structure opposite the projection has a Class A surface.